Making Africa a competitor in the Global Pharmaceutical Industry:

Federation of African Pharmaceutical Manufacturers

Associations (FAPMA)

Dr Skhumbuzo Ngozwana

The Parliamentary Roundtable

Midrand, South Africa 25 – 26 March 2014

PMPA Vision

To develop a competitive and enduring integrated pharmaceutical manufacturing industry in Africa, able to respond to the

continent’s need for a secure and reliable supply of quality, affordable, accessible,

safe and efficacious medicines.

2

3

African Pharma Value Chain

4

African Pharma growth drivers

Future disease burden

60 million people with hypertension by 2020 1 million cases of cancer annually 18.6 million people with diabetes by 2020 Other CVS, chronic respiratory diseases (COPD /

asthma) and neuro-psychiatric conditions NCD’s will have surpassed infectious diseases as the leading cause

of death in Africa by 2030.

Source: WHO, WHO AFRO, Frost & Sullivan analysis

6

Key PMPA Success Factors

There will be skeptics!Lord Kelvin, President of the Royal Society 1890-1895

“Radio has no future”

“Heavier than air flying machines are impossible”

“X-rays will prove to be a hoax”

“No Indian company can make an API that meets our

specifications”

Global R&D company in letter to Dr Reddys in 1984

8

There will be skeptics!

“Pharma is amongst the best performing sectors in Africa; the industry has been growing at a steady rate over the past few years and this momentum is

expected to continue in tandem with overall economic growth

being witnessed in Africa”

Ahmed Badreldin, Partner and Head of MENA at The Abraaj Group